Original Report
You have free access to this content
A systematic review of validated methods for identifying depression using administrative data
Article first published online: 19 JAN 2012
DOI: 10.1002/pds.2310
Copyright © 2012 John Wiley & Sons, Ltd.
Issue

Pharmacoepidemiology and Drug Safety
Supplement: The U.S. Food and Drug Administration's Mini-Sentinel Program
Volume 21, Issue Supplement S1, pages 163–173, January 2012
Additional Information
How to Cite
Townsend, L., Walkup, J. T., Crystal, S. and Olfson, M. (2012), A systematic review of validated methods for identifying depression using administrative data. Pharmacoepidem. Drug Safe., 21: 163–173. doi: 10.1002/pds.2310
Publication History
- Issue published online: 19 JAN 2012
- Article first published online: 19 JAN 2012
Funded by
- Food and Drug Administration through the Department of Health and Human Services. Grant Number: HHSF223200910006I
REFERENCES
- 1. Epidemiological context of signalling. Drug Saf 2007; 30(7): 611–613.
- 2World Health Organization. The Global Burden of Disease: 2004 Update. 2004. Available at: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. [1/16/2011].
- 3The Observational Medical Outcomes Partnership (OMOP). Health Outcomes of Interest. Available at: http://omop.fnih.org/HOI. [6/4/2010].
- 4, . Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012; 21(S1): 82–89.
- 5, , , et al. Quality of mental health care for youth with asthma and comorbid anxiety and depression. Med Care 2006; 44: 1064–1072. DOI: 10.1097/01.mlr.0000237421.17555.8f
- 6, , , et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care 2004; 42: 1222–1229. DOI: 10.1097/00005650-200412000-00009
- 7, , , et al. Using administrative data to identify mental illness: What approach is best? Am J Med Quality 2010; 25(1): 42–50. DOI: 10.1177/10628606093446347
- 8, , , et al. Identifying physician-recognized depression from administrative data: Consequences for quality measurement. Health Serv Res 2003; 38: 1081–1102. DOI: 10.1111/1475-6773.00164
- 9, , , et al. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual 2006; 21: 238–245. DOI: 10.1177/1062860606288243
- 10. How well do automated performance measures assess guideline adherence for new-onset depression in the Veterans Health Administration? Joint Comm J Quality & Safety 2003; 9: 479–489.
- 11, , , et al. Antidepressant adequacy and work status among Medicaid enrollees with disabilities: A restriction-based, propensity score-adjusted analysis. Community Ment Health J 2009; 45: 333–340.
- 12, , , et al. Recognition of depression in older medical inpatients discharged to ambulatory care settings: A longitudinal study. Gen Hosp Psychiatry 2008; 30: 245–251. DOI: 10.1016/j.genhosppsych.2008.01.006
- 13, , , et al. When depression is the diagnosis, what happens to patients and are they satisfied? Am J Manag Care 2003; 9: 131–140.
- 14, , , et al. Assessing the prevalence of depression among individuals with diabetes in a Medicaid managed-care program. Int J Psychiatry Med 2008; 38: 13–29.
- 15, , . Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 191–199. Reference ID: 10219.
- 16. The CES-D scale: A self report depression scale for research in the general population. Applied Psychological Measurement 1977; 1: 385–401. DOI: 10.1007/BF00788238
- 17, , . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–613. DOI: 10.1046/j.1525-1497.2001.016009606.x
- 18, . The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174. DOI: 10.2307/2529310
- 19, . Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff 2011; 30: 1434–1442. DOI: 10.1377/hlthaff.2010.1024
- 20, , . Case finding for depression among medical outpatients in the Veterans Health Administration. Med Care 2006; 44: 175–181. DOI: 10.1097/01.mlr.0000196962.97345.21
- 21. Recognition of mental distress and diagnosis of mental disorder in primary care. JAMA 1985; 253: 1903–1907. DOI: 10.1001/jama.253.13.1903
- 22, , , et al. The role of competing demands in the treatment provided primary care patients with major depression. Arch Fam Med 2000; 9: 150–154. DOI: 10.1001/archifami.9.2.150
- 23, , . Why do general practitioners recognize major depression in one woman patient yet miss it in another? Br J Gen Practice 1993; 43(373): 327–30.
- 24, , , et al. National trends in the outpatient treatment of depression. JAMA 2002; 287: 203–209. DOI: 10.1001/jama.287.2.203
- 25, , , et al. The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095–3105. DOI: 10.1001/jama.289.23.3095
- 26, . National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009; 66: 848–856. DOI: 10.1001/archgenpsychiatry.2009.81
- 27Screening for Depression in Adults. December 2009. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsaddepr.htm
- 28, , , et al. Screening for child and adolescent depression in primary care settings: A systematic evidence review for the US Preventive Services Task Force. Pediatrics 2009; 123(4): e716–e735. DOI: 10.1542/peds.2008-2415
- 29, , , et al. Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005; 62: 1097–1106. DOI: 10.1001/archpsyc.62.10.1097
- 30, , , et al. Detection of depressive disorder for patients receiving prepaid or fee-for-service care: results from the Medical Outcomes Study. JAMA 1989; 262(23): 3298–302. DOI: 10.1001/jama.262.23.3298.
- 31, , , et al. Depression diagnosis and antidepressant treatment among depressed VA primary care patients. Adm Policy Ment Health & Ment Health Serv Res 2006; 33: 331–341. DOI: 10.1007/s10488-006-0043-5.
- 32, , , et al. Targeting quality improvement activities for depression: implications of using administrative data. J Fam Practice 2000; 49(8): 721–8.
- 33, , , et al. The cost-utility of screening for depression in primary care. Ann Intern Med 2001; 134: 345–360.
- 34, , , et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 2000; 12(283): 212–220. DOI: 10.1001/jama.283.2.212.
- 35, . Changing perceptions of depression: Ten-year trends from the general social survey. Psychiatr Serv 2009; 60: 306–312. DOI: 10.1176/appi.ps.60.3.306.
- 36, , , et al. The deliberate misdiagnosis of major depression in primary care. Arch Fam Med 1994; 3(4): 333–7. DOI: 10.1001/archfami.3.4.333.
- 37, , , et al. Psychological distress and help seeking in rural America. Am J Commun Psychology 1997; 25(4): 449–70. DOI: 10.1023/A:1024655521619.
- 38, , , et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997; 277(4): 333–40. DOI: 10.1001/jama.277.4.333.
- 39, . Epidemiology of depression in primary care. Gen Hosp Psychiatry 1992; 14: 237–247.
- 40, . Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom 2004; 73: 207–215. DOI: 10.1159/000077739.
- 41, . Isotretinoin use and subsequent depression and suicide: Presenting the evidence. Am J Clin Derm 2003; 4: 493–505. DOI: 10.2165/00128071-200304070-00005.
- 42, , , et al. Diagnosis of nonpsychotic patients in community clinics. Am J Psychiatry 2000; 157: 581–587. DOI: 10.1176/appi.ajp.157.4.581.
- 43, , . Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006; 63: 332–339. DOI: 10.1001/archpsyc.63.3.332.
- 44, , , et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration BMJ 2009; 339: b2880. DOI: 10.1136/bmj.b2880.

1099-1557/asset/PDS_left.gif?v=1&s=f962ae698249deba4dc56217f1bb95eac528fe4d)
1099-1557/asset/PDS_right.gif?v=1&s=44103455c6e4e28135198609bb6a426efee9a51c)